Integra LifeSciences adopts Change in Control Severance Program effective Jan 1, 2025, renewing expiring program

INTEGRA LIFESCIENCES HOLDINGS CORP

Program covers named executives including CFO Lea Knight, with severance multiple of 2x (1.5x for others) base salary plus target bonus.
Qualifying termination (without cause or for good reason) within 2 years after a change in control triggers lump-sum severance, prorated bonus, COBRA for 18 months, and outplacement.
Program term runs through Dec 31, 2025, with automatic extension upon a change in control until 2-year anniversary.
Benefits subject to general release of claims and potential 'best pay cap' reduction for excise tax under Section 4999.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.